Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Zhenyu Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Sirtuin 3, Diterpenes, Kaurane, Zebrafish, Cardiotonic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Scientific and Technological Planning Project of Guangzhou City.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) persist as the predominant cause of mortality, urging the exploration of innovative pharmaceuticals. Mitochondrial dysfunction stands as a pivotal contributor to CVDs development. Sirtuin 3 (SIRT3), a prominent mitochondrial deacetylase known for its crucial role in protecting mitochondria against damage and dysfunction, has emerged as a promising therapeutic target for CVDs treatment. Utilizing isosteviol, a natural ent-beyerene diterpenoid, 24 derivatives were synthesized and evaluated in vivo using a zebrafish model, establishing a deduced structure-activity relationship. Among these, derivative 5v exhibited significant efficacy in doxorubicin-induced cardiomyopathy in zebrafish and murine models. Subsequent investigations revealed that 5v selectively elevated SIRT3 expression, leading to the upregulation of SOD2 and OPA1 expression, effectively preventing mitochondrial dysfunction, mitigating oxidative stress, and preserving cardiomyocyte viability. As a novel structural class of SIRT3 activators with robust therapeutic effects, 5v emerges as a promising candidate for further drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
ORCID-Profile: Yu Zhao
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Scientific and Technological Planning Project of Guangzhou City
Zitieren
APA
Chen, Z., Li, Z., Xu, R., Xie, Y., Li, D., & Zhao, Y. (2024). Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00345
Vancouver
Chen Z, Li Z, Xu R, Xie Y, Li D, Zhao Y. Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00345
BibTeX
@article{Chen2024,
author = {Chen, Zhenyu and Li, Zhiyin and Xu, Ruilong and Xie, Yufeng and Li, Dehuai and Zhao, Yu},
title = {Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00345}
}
EUVIMED